X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24317) 24317
Newsletter (1688) 1688
Publication (1300) 1300
Book Review (92) 92
Book Chapter (48) 48
Conference Proceeding (29) 29
Dissertation (29) 29
Newspaper Article (18) 18
Transcript (6) 6
Magazine Article (5) 5
Government Document (4) 4
Paper (4) 4
Web Resource (4) 4
Report (3) 3
Book / eBook (2) 2
Journal / eJournal (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18696) 18696
etoposide (12134) 12134
male (10179) 10179
oncology (9808) 9808
female (9804) 9804
etoposide - administration & dosage (9138) 9138
antineoplastic combined chemotherapy protocols - therapeutic use (9019) 9019
adult (7483) 7483
middle aged (7418) 7418
chemotherapy (6637) 6637
index medicus (5315) 5315
aged (5310) 5310
cancer (5235) 5235
cisplatin - administration & dosage (4039) 4039
etoposide - pharmacology (3980) 3980
treatment outcome (3519) 3519
cisplatin (3434) 3434
antineoplastic combined chemotherapy protocols - adverse effects (3166) 3166
adolescent (3077) 3077
combined modality therapy (3047) 3047
hematology (2942) 2942
lung neoplasms - drug therapy (2914) 2914
cyclophosphamide - administration & dosage (2803) 2803
animals (2773) 2773
apoptosis (2679) 2679
etoposide - therapeutic use (2643) 2643
antineoplastic combined chemotherapy protocols - administration & dosage (2394) 2394
etoposide - adverse effects (2368) 2368
doxorubicin - administration & dosage (2296) 2296
prognosis (2254) 2254
vincristine - administration & dosage (2145) 2145
research (2127) 2127
care and treatment (2073) 2073
child (1896) 1896
survival rate (1865) 1865
drug administration schedule (1819) 1819
therapy (1801) 1801
remission induction (1772) 1772
carboplatin - administration & dosage (1731) 1731
apoptosis - drug effects (1672) 1672
cyclophosphamide (1669) 1669
neoplasm staging (1666) 1666
mice (1628) 1628
retrospective studies (1613) 1613
survival analysis (1610) 1610
disease-free survival (1572) 1572
pharmacology & pharmacy (1554) 1554
carcinoma, small cell - drug therapy (1531) 1531
carboplatin (1482) 1482
child, preschool (1460) 1460
dose-response relationship, drug (1428) 1428
tumors (1424) 1424
antineoplastic agents - pharmacology (1412) 1412
biochemistry & molecular biology (1394) 1394
cytarabine - administration & dosage (1392) 1392
bleomycin - administration & dosage (1391) 1391
carcinoma (1367) 1367
cell line, tumor (1348) 1348
ifosfamide - administration & dosage (1347) 1347
follow-up studies (1322) 1322
transplantation (1291) 1291
survival (1280) 1280
lung neoplasms - pathology (1200) 1200
tumor cells, cultured (1198) 1198
doxorubicin (1194) 1194
radiotherapy (1184) 1184
time factors (1181) 1181
dna damage (1156) 1156
cell biology (1141) 1141
drugs (1119) 1119
expression (1106) 1106
aged, 80 and over (1099) 1099
antineoplastic agents - therapeutic use (1097) 1097
infant (1086) 1086
trial (1080) 1080
methotrexate - administration & dosage (1036) 1036
analysis (1033) 1033
antineoplastic agents, phytogenic - pharmacology (1023) 1023
children (982) 982
combination chemotherapy (970) 970
salvage therapy (956) 956
lung cancer (949) 949
pediatrics (938) 938
medicine & public health (932) 932
transplantation, autologous (929) 929
phase-ii (919) 919
ifosfamide (915) 915
recurrence (909) 909
prednisone - administration & dosage (893) 893
cisplatin - adverse effects (888) 888
carcinoma, non-small-cell lung - drug therapy (886) 886
leukemia (879) 879
young adult (872) 872
testicular neoplasms - drug therapy (852) 852
drug resistance, neoplasm (850) 850
prospective studies (844) 844
hematopoietic stem cell transplantation (836) 836
drug resistance (822) 822
surgery (816) 816
health aspects (802) 802
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23867) 23867
Japanese (1044) 1044
German (283) 283
French (273) 273
Chinese (234) 234
Spanish (99) 99
Russian (93) 93
Polish (54) 54
Italian (45) 45
Korean (35) 35
Hungarian (20) 20
Portuguese (16) 16
Czech (12) 12
Turkish (11) 11
Dutch (8) 8
Serbian (8) 8
Hebrew (6) 6
Croatian (4) 4
Danish (2) 2
Norwegian (2) 2
Romanian (2) 2
Swedish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomarker Research, ISSN 2050-7771, 12/2019, Volume 7, Issue 1, pp. 1 - 1
The original article [1] contains an error in the legend of Fig. 1 whereby it is incorrectly stated that MEC stands for ‘mitoprostate cancer using magnetic... 
Etoposide
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2017, Volume 38, p. A205-A206
Le syndrome d'activation macrophagique (SAM) ou lympho-histiocytose hemophagocytaire est une entite clinico-biologique rare pouvant compliquer plusieurs... 
Etoposide
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2017, Volume 38, p. A205
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.03.303 Le... 
Etoposide
Journal Article
EXCLI Journal, 01/2015, Volume 14, pp. 95 - 108
Journal Article
Journal of Thermal Analysis and Calorimetry, ISSN 1388-6150, 03/2014, Volume 115, Issue 3, p. 2369
The effects of podophyllotoxin (PPT), etoposide (VP16), and teniposide (VM26) on the growth of Tetrahy mena thermophila [BF.sub.5] (T.t.[BF.sub.5]) was... 
Etoposide
Journal Article
Science, ISSN 0036-8075, 7/2011, Volume 333, Issue 6041, pp. 459 - 462
Journal Article
Apoptosis - An International Journal on Programmed Cell Death, ISSN 1360-8185, 06/2008, Volume 13, Issue 6, p. 756
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) binds to death receptor 4 (DR4) activating the apoptotic signalling pathway. DNA damaging... 
Etoposide
Journal Article
ACS Nano, ISSN 1936-0851, 03/2018, Volume 12, Issue 3, pp. 2426 - 2439
Journal Article
Phase II study of cisplatin, etoposide and paclitaxel in locally advanced or metastatic adenocarcinoma of gastric/ gastroesophageal junction, 12/2006
Background: Unresectable and metastatic gastric cancers carry a poor and dismal prognosis. Several phase II studies have identified effective anticancer drugs.... 
Cisplatin, etoposide, gastric, gastroesophageal, paclitaxel
Journal
British Journal of Haematology, ISSN 0007-1048, 04/2015, Volume 169, Issue 2, pp. 188 - 198
Summary This prospective multi‐institutional phase II study was designed to assess the efficacy and safety of dose‐adjusted EPOCH (etoposide,... 
vincristine | and rituximab | large B‐cell lymphoma | cyclophosphamide | doxorubicin | dose‐adjusted‐EPOCH‐R (etoposide, prednisone | high‐risk patients | cell of origin | Dose-adjusted-EPOCH-R (etoposide, prednisone | Cyclophosphamide | And rituximab | Cell of origin | Large B-cell lymphoma | High-risk patients | Doxorubicin | Vincristine | SURVIVAL | DLBCL | BCL-2 GENE | REGIMEN | GERMINAL CENTER | CHEMOTHERAPY | high-risk patients | large B-cell lymphoma | PROTEIN EXPRESSION | dose-adjusted-EPOCH-R (etoposide | NON-HODGKINS-LYMPHOMA | CHOP | TISSUE MICROARRAY | prednisone | HEMATOLOGY | Doxorubicin - therapeutic use | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Neoplasm Grading | Adult | Female | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Lymphoma, Large B-Cell, Diffuse - pathology | Rituximab | Etoposide - therapeutic use | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Medical research | Anthracyclines | Corticosteroids | Analysis | Clinical trials | Medicine, Experimental | Etoposide | Lymphomas | Prednisone | Index Medicus
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 04/2010, Volume 53, Issue 7, pp. 2814 - 2824
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 01/2020, Volume 106, p. 110275
Etoposide (ETS), topoisomerase-II inhibitor, is a first-line anticancer therapeutics used in diverse cancer types. However, the therapeutic potential of this... 
Etoposide toxicity | Etoposide delivery | Patent and clinical trials | Pharmacological advances | Etoposide solubility
Journal Article
Nature Medicine, ISSN 1078-8956, 01/2007, Volume 13, Issue 1, pp. 54 - 61
Anthracyclin-treated tumor cells are particularly effective in eliciting an anticancer immune response, whereas other DNA-damaging agents such as etoposide and... 
MEDICINE, RESEARCH & EXPERIMENTAL | CLEARANCE | DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR | CHAPERONE | CELL BIOLOGY | DYING CELLS | APOPTOTIC CELLS | SURFACE CALRETICULIN | ENDOPLASMIC-RETICULUM | ENCODING CALRETICULIN | ANTIGEN | Apoptosis - drug effects | Colonic Neoplasms - drug therapy | Dendritic Cells - immunology | Electrophoresis, Gel, Two-Dimensional | Immunoblotting | Antineoplastic Agents - therapeutic use | Protein Transport - drug effects | Calreticulin - genetics | Colonic Neoplasms - metabolism | Cell Cycle Proteins - antagonists & inhibitors | RNA Interference | Anthracyclines - pharmacology | Neoplasms, Experimental - immunology | Calreticulin - metabolism | Antigens, Differentiation - metabolism | Antineoplastic Agents - pharmacology | Cell Membrane - metabolism | Protein Phosphatase 1 | Cell Membrane - drug effects | Mitomycin - therapeutic use | Cell Cycle Proteins - metabolism | Phagocytosis - immunology | Etoposide - pharmacology | Etoposide - therapeutic use | Recombinant Proteins - pharmacology | Mitomycin - pharmacology | Animals | Apoptosis - immunology | Mice, Nude | Colonic Neoplasms - pathology | Cell Line, Tumor | Cell Membrane - immunology | Mice | Mice, Inbred BALB C | Anthracyclines - therapeutic use | Calreticulin - immunology | Neoplasms, Experimental - metabolism | Neoplasms, Experimental - drug therapy | Chemotherapy | Immunology | DNA damage | Rodents | Cancer | Apoptosis | Tumors | Antigens, Differentiation | Cell Membrane | Anthracyclines | Dendritic Cells | Recombinant Proteins | Life Sciences | Calreticulin | Neoplasms, Experimental | Mitomycin | Etoposide | Antineoplastic Agents | Protein Transport | Phagocytosis | Cell Cycle Proteins | Colonic Neoplasms
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 07/2019, Volume 457, Issue 1-2, p. 21
Journal Article